The glaucoma surgery devices market is on a steady rise, fueled by the growing prevalence of glaucoma, aging populations, and advancements in surgical technologies. Increasing awareness and early diagnosis efforts are further accelerating demand, with the market projected to reach USD 2.79 billion by 2034 at a CAGR of 4.60%. Ask ChatGPT
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Glaucoma Surgery Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Glaucoma Surgery Devices Market Revenue and Volume, by Product
8.1.1 Glaucoma Drainage Device
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Traditional Surgery Devic
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Diamond Knives
8.1.3.1. Market Revenue and Volume Forecast
9.1. Glaucoma Surgery Devices Market Revenue and Volume, by Surgery Method
9.1.1. Traditional Glaucoma Surgery
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Minimal Invasive Glaucoma Surgery
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Laser Surgery
9.1.3.1. Market Revenue and Volume Forecast
10.1. Glaucoma Surgery Devices Market Revenue and Volume, by End-user
10.1.1. Hospitals
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Ophthalmic Clinics
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Others
10.1.3.1. Market Revenue and Volume Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Product
11.1.2. Market Revenue and Volume Forecast, by Surgery Method
11.1.3. Market Revenue and Volume Forecast, by End-user
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Product
11.1.4.2. Market Revenue and Volume Forecast, by Surgery Method
11.1.4.3. Market Revenue and Volume Forecast, by End-user
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Product
11.1.5.2. Market Revenue and Volume Forecast, by Surgery Method
11.1.5.3. Market Revenue and Volume Forecast, by End-user
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Product
11.2.2. Market Revenue and Volume Forecast, by Surgery Method
11.2.3. Market Revenue and Volume Forecast, by End-user
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Product
11.2.4.2. Market Revenue and Volume Forecast, by Surgery Method
11.2.4.3. Market Revenue and Volume Forecast, by End-user
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Product
11.2.5.2. Market Revenue and Volume Forecast, by Surgery Method
11.2.5.3. Market Revenue and Volume Forecast, by End-user
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Product
11.2.6.2. Market Revenue and Volume Forecast, by Surgery Method
11.2.6.3. Market Revenue and Volume Forecast, by End-user
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Product
11.2.7.2. Market Revenue and Volume Forecast, by Surgery Method
11.2.7.3. Market Revenue and Volume Forecast, by End-user
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Product
11.3.2. Market Revenue and Volume Forecast, by Surgery Method
11.3.3. Market Revenue and Volume Forecast, by End-user
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Product
11.3.4.2. Market Revenue and Volume Forecast, by Surgery Method
11.3.4.3. Market Revenue and Volume Forecast, by End-user
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Product
11.3.5.2. Market Revenue and Volume Forecast, by Surgery Method
11.3.5.3. Market Revenue and Volume Forecast, by End-user
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Product
11.3.6.2. Market Revenue and Volume Forecast, by Surgery Method
11.3.6.3. Market Revenue and Volume Forecast, by End-user
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Product
11.3.7.2. Market Revenue and Volume Forecast, by Surgery Method
11.3.7.3. Market Revenue and Volume Forecast, by End-user
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Product
11.4.2. Market Revenue and Volume Forecast, by Surgery Method
11.4.3. Market Revenue and Volume Forecast, by End-user
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Product
11.4.4.2. Market Revenue and Volume Forecast, by Surgery Method
11.4.4.3. Market Revenue and Volume Forecast, by End-user
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Product
11.4.5.2. Market Revenue and Volume Forecast, by Surgery Method
11.4.5.3. Market Revenue and Volume Forecast, by End-user
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Product
11.4.6.2. Market Revenue and Volume Forecast, by Surgery Method
11.4.6.3. Market Revenue and Volume Forecast, by End-user
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Product
11.4.7.2. Market Revenue and Volume Forecast, by Surgery Method
11.4.7.3. Market Revenue and Volume Forecast, by End-user
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Product
11.5.2. Market Revenue and Volume Forecast, by Surgery Method
11.5.3. Market Revenue and Volume Forecast, by End-user
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Product
11.5.4.2. Market Revenue and Volume Forecast, by Surgery Method
11.5.4.3. Market Revenue and Volume Forecast, by End-user
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Product
11.5.5.2. Market Revenue and Volume Forecast, by Surgery Method
11.5.5.3. Market Revenue and Volume Forecast, by End-user
12.1. Alcon, Inc
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Glaukos Corporation
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Johnson & Johnson Vision
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. AbbVie Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. ASICO, LLC
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Carl Zeiss Meditec AG
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Katalyst Surgical
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Lumenis Lt.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Ziemer Ophthalmic Systems AG
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Iridex Corporation.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description